Eterna Therapeutics Inc. Banner Image

Eterna Therapeutics Inc.

  • Ticker ERNA
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Eterna Therapeutics Inc. Logo Image
  • 11-50 Employees
  • Based in Cambridge, Massachusetts
Eterna Therapeutics is a life science company committed to realizing the potential of mRNA cell engineering to provide patients with transformational new medicines. Eterna has in-licensed a portfolio of over 130 patents covering key mRNA cell engineering technologies, including technologies for mRNA cell reprogramming, mRNA gene editing, the NoveSlice™ and UltraSlice™ gene-editing proteinsMore, and the ToRNAdo™ mRNA delivery system from Factor Bioscience. NoveSlice™, UltraSlice™, and ToRNAdo™ are trademarks of Factor Bioscience.
3.0 / 5.0 (3)

Eterna Therapeutics Inc. reports have an aggregate usefulness score of 3.0 based on 3 reviews.

Eterna Therapeutics Inc.

Most Recent Annual Report

Eterna Therapeutics Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Eterna Therapeutics Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!